On Invalid Date, Atai Life Sciences Nv (NASDAQ: ATAI) reported Q1 2023 earnings per share (EPS) of -$0.21, up 12.5% year over year. Total Atai Life Sciences Nv earnings for the quarter were -$33.14 million. In the same quarter last year, Atai Life Sciences Nv's earnings per share (EPS) was -$0.24.
As of Q2 2023, Atai Life Sciences Nv's earnings has grown year over year. Atai Life Sciences Nv's earnings in the past year totalled -$148.65 million.
What was ATAI's revenue last quarter?
On Invalid Date, Atai Life Sciences Nv (NASDAQ: ATAI) reported Q1 2023 revenue of $37.00 thousand up Infinity% year over year. In the same quarter last year, Atai Life Sciences Nv's revenue was $0.00.
What was ATAI's revenue growth in the past year?
As of Q2 2023, Atai Life Sciences Nv's revenue has grown -45.77% year over year. This is 114.98 percentage points lower than the US Biotechnology industry revenue growth rate of 69.21%. Atai Life Sciences Nv's revenue in the past year totalled $269.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.